Last updated: 2026-11-14 22:01:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Milestone Pharmaceuticals Inc. (MIST) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.52, with a market capitalization of $81.57M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.50 to $3.06. This page covers its latest market performance, valuation, price trends and company information.
$81.57M | |
$0.70 | |
$0.73 | |
$0.50 | |
$0.66 | |
3.89M | |
1.37M | |
-- | |
$3.06 | |
$0.50 | |
-- | |
-- |
Milestone Pharmaceuticals Inc. (MIST) last closed at $0.52 as of 2026-11-14 00:59:00, down 20.62% ($0.14) from the previous close of $0.66.
During the latest regular trading session, MIST traded between $0.50 and $0.73, with a volume of 3.89M shares. The closing price was near the lower end and near the lower end of its 52-week range.
MIST is down 1.08% as of the last close.
Over the past seven days, Milestone Pharmaceuticals Inc. (MIST) moved from $0.69 to $0.52, representing a decline of 24.91% ($0.17).
The stock traded between $0.50 and $0.79 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.54 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.8%
MIST is currently trading at $0.52, placing it 0.8% of the way from its 52-week low of $0.50 to its 52-week high of $3.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Milestone Pharmaceuticals Inc. and MIST stock.
Key elements of the cost-efficiency measures include:Bringing the sales force in-house: the Company plans to retain the existing field sales team of approximately 45 dedicated representatives, transitioning them from a
Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 50 percent decrease over losses of $(0.12) per
Eligible investors can buy real shares of Milestone Pharmaceuticals Inc. (MIST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MIST, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between MIST shares and USD.
MIST Shares to USD
1.00 MIST shares = 0.52 USD
Calculations are estimates based on the latest available price and are for reference only.
